Weiguo Ye, Chief Operating Officer at GYRE THERAPEUTICS, INC. (GYRE), sold 11,000 shares at $6.15 ($69K) on 2026-06-09, disclosed to the SEC on 2026-06-22.
Open-market sale of $69k GYRE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.15 | 3,000 | $18K | 26.9% |
| 2 | $6.24 | 5,000 | $31K | 45.4% |
| 3 | $6.35 | 3,000 | $19K | 27.7% |
| Total | $6.25 avg | 11,000 | $69K | 100% |
| Filing → |
| GYRE | SELL | 2026-06-08 | $219K | — | Filing → |
| GYRE | SELL | 2026-05-27 | $46K | — | Filing → |
| GYRE | SELL | 2026-05-22 | $137K | — | Filing → |